Contents

Current Pharmaceutical Design, Volume 12 - Number 28

Editorial [Hot Topic: Membrane Channels as Therapeutic Targets (Executive Editor: Jean-Claude Herve)]

, 12(28): 3571 - 3572

Jean-Claude Herve


DOI: 10.2174/138161206778522074




Muscarinic Acetylcholine Receptors

, 12(28): 3573 - 3581

Masaru Ishii and Yoshihisa Kurachi


DOI: 10.2174/138161206778522056




Pharmacological Intervention at Ionotropic Glutamate Receptor Complexes

, 12(28): 3583 - 3596

Rosa Planells-Cases, Juan Lerma and Antonio Ferrer-Montiel


DOI: 10.2174/138161206778522092




The Pharmacology of Cyclic Nucleotide-Gated Channels: Emerging from the Darkness

, 12(28): 3597 - 3613

R. Lane Brown, Timothy Strassmaier, James D. Brady and Jeffrey W. Karpen


DOI: 10.2174/138161206778522100




5-HT3 Receptors

, 12(28): 3615 - 3630

A. J. Thompson and S. C. R. Lummis


DOI: 10.2174/138161206778522029




Molecular Mechanisms of Cardiac Voltage-Gated Potassium Channelopathies

, 12(28): 3631 - 3644

Geoffrey W. Abbott


DOI: 10.2174/138161206778522065




Mechanosensitive Channels: Therapeutic Targets in the Myocardium?

, 12(28): 3645 - 3663

Ed White


DOI: 10.2174/138161206778522083




Anaesthetic Drugs: Linking Molecular Actions to Clinical Effects

, 12(28): 3665 - 3679

Christian Grasshoff, Berthold Drexler, Uwe Rudolph and Bernd Antkowiak


DOI: 10.2174/138161206778522038




Voltage-Gated Sodium Channels: New Targets in Cancer Therapy?

, 12(28): 3681 - 3695

Sebastien Roger, Marie Potier, Christophe Vandier, Pierre Besson and Jean-Yves Le Guennec


DOI: 10.2174/138161206778522047




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science